A CRISPR gene editing treatment continues to show promise for two blood diseases
Bio Pharma Dive
DECEMBER 5, 2020
Results from 10 patients with beta thalassemia or sickle cell disease show CRISPR Therapeutics and Vertex's pioneering treatment to be effective, building on earlier study data.
Let's personalize your content